Search

for
Search:

GlossaryHydroxyurea

medication that inhibits DNA synthesis to treat cancer and blood disorders

Hydroxyurea, also known as hydroxycarbamide, is a medication primarily used to treat certain types of cancer, such as chronic myelogenous leukemia, and blood disorders like sickle cell anemia. It works by inhibiting DNA synthesis, which helps to slow the growth of cancer cells and reduce the frequency of painful sickle cell crises.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 280 results

research Genital Dermatology: Case Studies and Research Findings

April 2022 in “Australasian Journal of Dermatology”

Skin changes during pregnancy are common, and non-invasive imaging is safe for monitoring these changes.

research Mucocutaneous Side Effects of Antineoplastic Chemotherapy

55 citations , November 2004 in “Expert opinion on drug safety”

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Hydrochlorothiazide/Indometacin: Lupus Erythematosus in a 73-Year-Old Woman After Hydroxycarbamide Treatment for Essential Thrombocythemia

research Hydrochlorothiazide/Indometacin: Lupus Erythematosus in a 73-Year-Old Woman After Hydroxycarbamide Treatment for Essential Thrombocythemia

October 2009 in “Reactions Weekly”

A woman developed lupus after taking hydroxyurea for two years.

research Dermatological Drugs, Topical Agents, And Cosmetics

1 citations , January 2005 in “Side effects of drugs annual”

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

research Psoriatic Alopecia

41 citations , July 2015 in “Clinical and Experimental Dermatology”

Psoriasis can cause temporary or permanent hair loss.

View more "hydroxyurea" in research →

Community Join

0 / 0 results

— no results